Day: December 30, 2024
Company Announcement No 62/2024Peberlyk 46200 AabenraaDenmark
Tel +45 74 37 37 37Fax +45 74 37 35 36
Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk30 December 2024
Dear Sirs
Sydbank share buyback programme: transactions in week 52On 28 February 2024 Sydbank announced a share buyback programme of DKK 1,200m. The share buyback programme commenced on 4 March 2024 and will be completed by 31 January 2025.
The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules.
The following transactions have been made under the share...
Share buyback programme – week 52
Written by Customer Service on . Posted in Public Companies.
Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeDanish Financial Supervisory AuthorityOther stakeholders
Date 30 December 2024
Share buyback programme – week 52
The share buyback programme runs in the period 1 February 2024 up to and including 27 January 2025, see company announcement of 31 January 2024. Part I of the programme, for DKK 750 million, was completed on 27 June 2024, see company announcement of 28 June 2024. Part II of the programme, for DKK 775 million and a maximum of 1,550,000 shares, is for execution in the period 28 June 2024 – 27 January 2025.
The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” rules.
The following transactions have...
Himax to Introduce Expanded WiseEye PalmVein Suite at CES 2025 Featuring Groundbreaking Bimodal Palm Vein and Face Authentication Technologies for Multimodal Authentication
Written by Customer Service on . Posted in Public Companies.
Redefining Biometric Security for Smart Door Locks with Ultralow Power WiseEye PalmVein and Face Authentication Technologies for Rapid, Contactless, and Adaptive Identity Verification
TAINAN, Taiwan, Dec. 30, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq: HIMX), an industry leader in fabless display driver ICs and other semiconductors, today announced the Company will introduce its expanded WiseEyeTM PalmVein suite at CES 2025, featuring groundbreaking bimodal palm vein and face authentication technologies. This game-changing, contactless, ultralow power bimodal biometric authentication is designed to enhance both security and user friendliness in smart door locks. By leveraging multiple personal biometric traits for authentication, the newly introduced solution delivers unparalleled security,...
Endeavour Announces Transaction in Own Shares
Written by Customer Service on . Posted in Public Companies.
ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES
London, 30 December 2024 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited.
Aggregated informationDates of purchase:
27 December 2024Aggregate number of ordinary shares of USD 0.01 each purchased:
23,452Lowest price paid per share (GBp):
1,415.00Highest price paid per share (GBp):
1,445.59Volume weighted average price paid per share (GBp):
1,416.40Following the cancellation of the repurchased shares, the Company will have no ordinary shares in treasury and 244,036,385 ordinary shares in issue. Therefore the total voting rights in the Company will be 244,036,385. This figure for the total number of voting...
Vastned Belgium and Vastned Retail expect to complete their reverse cross-border legal merger on 1 January 2025
Written by Customer Service on . Posted in Mergers And Acquisitions.
In line with required notification periods for listing purposes, Vastned Belgium (Vastned Belgium NV, Euronext Brussels: VASTB, a public regulated real estate company (GVV/SIR)) announces today that it expects that the reverse cross-border legal merger, in which Vastned Retail (Vastned Retail N.V., Euronext Amsterdam: VASTN) would merge with and into Vastned Belgium (Merger), will enter into force on 1 January 2025 at 00.00 am CET (i.e., start of the day) and Vastned Belgium will be renamed to “Vastned”.
Full press release:AttachmentVastned Belgium and Vastned Retail expect to complete their reverse cross-border legal merger on 1 January 2025
Dates of publication of AB “Rokiškio sūris” Group results for 2025
Written by Customer Service on . Posted in Public Companies.
Rokiškio sūris, AB, announces that in 2025 the Group of Rokiškio sūris, AB, plans to publish its results in the following order:
8 April 2024, Audited consolidated financial statements of the Group.
29 August 2025, six-month consolidated financial statements of the Group.
Dalius Trumpa
CEO
+370 458 55200
Garden Stage Limited – Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Written by Customer Service on . Posted in Public Companies.
Hong Kong, Dec. 30, 2024 (GLOBE NEWSWIRE) — Garden Stage Limited (NASDAQ: GSIW) (“GSIW” or the “Company”), today announced that it received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on December 24, 2024 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq’s Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company’s ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price...
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
Written by Customer Service on . Posted in Public Companies.
Ad hoc announcement pursuant to Art. 53 LRThe Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal onasemnogene abeparvovec (OAV101 IT)
OAV101 IT is the first investigational gene therapy to provide clinical benefit in treatment-naïve patients with SMA aged two and older with a positive risk benefit profile
Novartis plans to share results with regulatory agencies in 2025 with the aim to make OAV101 IT available to help patients with SMA in needBasel, [December 30, 2024] – Novartis today announced positive topline results from the Phase III STEER study. This pivotal study assessed the efficacy and safety of investigational intrathecal onasemnogene abeparvovec (OAV101 IT) in treatment-naïve patients with spinal muscular atrophy (SMA) Type 2,...
WISeKey’s Subsidiary SEALCOIN 2025 Roadmap: Leading Machine-to-Machine Transactions Through Blockchain and Space Innovation
Written by Customer Service on . Posted in Public Companies.
WISeKey’s Subsidiary SEALCOIN 2025 Roadmap: Leading Machine-to-Machine Transactions Through Blockchain and Space Innovation
Zug, Switzerland — December 30, 2024 – WISeKey International Holding Ltd (“WISeKey” or the “Company”) (NASDAQ: WKEY; SIX: WIHN), a global leader in cybersecurity, AI, blockchain, and IoT technologies, that its subsidiary, SEALCOIN AG, ends 2024 as a leader in secure, decentralized IoT ecosystems. Utilizing its blockchain-based TIOT token, SEALCOIN empowers IoT devices to autonomously exchange data, energy, and services, transforming real-time interactions with unmatched trust and efficiency.
In January 2025, SEALCOIN will achieve a major milestone in cooperation with WISeSat AG, another WISeKey subsidiary which focuses on space technology for secure satellite communication, specifically for IoT applications,...
Anoto announces outcome of rights issue
Written by Customer Service on . Posted in Public Companies.
Anoto Group AB (the “Company” or “Anoto“) hereby announces the outcome of the Company’s rights issue of approximately SEK 50 million (the “Rights Issue”) for which the subscription period ended on 19 December 2024. The Rights Issue has been subscribed to approximately 37.5 percent with and without the support of subscription rights. Underwriting commitments of 259,308,520 shares, corresponding to approximately 62.5 percent of the Rights Issue, will thus be utilized. The Rights Issue provides the Company with proceeds of approximately SEK 50 million before transaction costs and before set-off of loans.
Final outcomeIn the Rights Issue, 154,891,590 shares were subscribed for with subscription rights, corresponding to approximately 37.3 percent of the Rights Issue. In addition, 623,720 shares were subscribed for without...